ClassID:

92682

C07C229/20 - CPC Classification

Classification description:

Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups

Recent Application in this class:
#1
20260055122
2026-02-26

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#2
20250333373
2025-10-30

L-2-Amino-4-Halobutyric Acid Derivative-L-Tartrate and Preparation Method Thereof

#3
20240423207
2024-12-26

PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY

#4
20230371516
2023-11-23

Picolinamide compounds with fungicidal activity

#5
20230242471
2023-08-03

THYROMIMETICS

#6
20220340604
2022-10-27

MODULATORS OF SESTRIN-GATOR2 INTERACTION AND USES THEREOF

#7
20220159962
2022-05-26

Picolinamide compounds with fungicidal activity

#8
20210047347
2021-02-18

Modulators of Sestrin-GATOR2 interaction and uses thereof

#9
20200120936
2020-04-23

Picolinamide compounds with fungicidal activity

#10
20200079800
2020-03-12

Modulators of Sestrin-GATOR2 interaction and uses thereof

#11
20190223814
2019-07-25

18F labeled amino acids, derivatives thereof and method of making same

#12
20190059383
2019-02-28

Use of picolinamide compounds as fungicides

#13
20190048029
2019-02-14

Modulators of sestrin-GATOR2 interaction and uses thereof

#14
20180228159
2018-08-16

Picolinamide compounds with fungicidal activity

#15
20180208544
2018-07-26

AN IMPROVED PROCESS FOR THE PREPARATION OF BACLOFEN AND ITS INTERMEDIATE

#16
20170348266
2017-12-07

Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications

#17
20170295792
2017-10-19

Use of picolinamide compounds as fungicides

#18
20170114080
2017-04-27

Modulators of sestrin-GATOR2 interaction and uses thereof

#19
20170057939
2017-03-02

Carboxylic acid derivatives and use thereof in the preparation of prodrugs

#20
20170050920
2017-02-23

Water-soluble propofol derivatives and uses thereof

#21
20150080598
2015-03-19

ASYMMETRIC SYNTHESIS FOR PREPARING FLUOROLEUCINE ALKYL ESTERS

#22
20150045575
2015-02-12

Process for preparing fluoroleucine alkyl esters

#23
20140288142
2014-09-25

Nitric oxide donor compounds

#24
20140100278
2014-04-10

Injectable formulation for treatment and protection of patients having an Inflammatory Reaction or an Ischemia-reperfusion event

#25
20140057873
2014-02-27

Nitric oxide releasing amino acid ester compound, composition and method of use

#26
20120219596
2012-08-30

INJECTABLE FORMULATION FOR TREATMENT AND PROTECTION OF PATIENTS HAVING AN INFLAMMATORY REACTION OR AN ISCHEMIA-REPERFUSION EVENT

#27
20110152536
2011-06-23

Process for production of α-trifluoromethyl-β-substituted-β-amino acid

#28
20110015428
2011-01-20

Process for producing α-fluoro-β-amino acids

#29
20100099729
2010-04-22

NITRIC OXIDE DONOR COMPOUNDS

#30
20090240041
2009-09-24

Tumor imaging compounds

#31
20090082591
2009-03-26

METHODS FOR PREPARING SULFONAMIDE COMPOUNDS

#32
20070249723
2007-10-25

Methods for preparing sulfonamide compounds

#33
20070112200
2007-05-17

Non-racemic trifluoroleucine, and methods of making and using

#34
20070027212
2007-02-01

Alpha 2 delta ligands for post-traumatic stress disorder

#35
20060183800
2006-08-17

Methods and fluorinated compositions for treating amyloid-related diseases

#36
20060030731
2006-02-09

Diastereoselective reductive amination process

#37
20060004103
2006-01-05

Method for producing lysine derivative

#38
20050234128
2005-10-20

Process for preparing fluoroleucine alkyl esters

#39
20050192458
2005-09-01

Tumor imaging compounds

#40
20050043547
2005-02-24

Process for producing optically active azetidine-2-carboxylic acids

#41
20050020837
2005-01-27

N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as Edg receptor agonists

#42
20050020683
2005-01-27

Process for preparing single enantiomers of 5,5,5,5′,5′,5′-hexafluoroleucine and protected analogs